Gene: PTHLH
Official Full Name: parathyroid hormone like hormoneprovided by HGNC
Gene Summary: The protein encoded by this gene is a member of the parathyroid hormone family. This hormone, via its receptor, PTHR1, regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. It is responsible for most cases of humoral hypercalcemia of malignancy, and mutations in this gene are associated with brachydactyly type E2 (BDE2). Alternatively spliced transcript variants have been found for this gene. There is also evidence for alternative translation initiation from non-AUG (CUG and GUG) start sites, downstream of the initiator AUG codon, resulting in nuclear forms of this hormone. [provided by RefSeq, Nov 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03418 | PTHLH Knockout cell line (HeLa) | Human | PTHLH | 1:3~1:6 | Negative | Online Inquiry |
KO03419 | PTHLH Knockout cell line (HEK293) | Human | PTHLH | 1:3~1:6 | Negative | Online Inquiry |
KO03420 | PTHLH Knockout cell line (A549) | Human | PTHLH | 1:3~1:4 | Negative | Online Inquiry |
PTHLH gene knockout cell lines are genetically modified cells in which the PTHLH (Parathyroid Hormone-Like Hormone) gene has been disrupted or inactivated. This innovative tool enables researchers to study the functional role of the PTHLH gene and its protein product in various biological processes, particularly those related to bone development and calcium homeostasis. The knockout strategy is specifically designed to eliminate the expression of PTHLH, providing a powerful model to observe phenotypic changes and cellular behaviors resulting from the absence of this gene.
These cell lines primarily facilitate investigations into signaling pathways linked to developmental biology, particularly the pathways involved in bone growth and mineralization. By using these knockout models, researchers can elucidate the molecular mechanisms underlying conditions such as osteoporosis and other metabolic bone diseases, where aberrations in PTHLH expression play a significant role. Furthermore, they provide a platform for drug testing and potential therapeutic interventions, allowing for the exploration of how targeting PTHLH pathways might influence bone health.
Unlike traditional cell line models, the PTHLH gene knockout cell lines offer distinct advantages. Their specificity allows for clearer interpretations of experimental data, reducing confounding variables that often cloud results in less targeted models. As a result, these cell lines stand out for their robustness, reliability, and utility in translational research aimed at addressing bone disorders.
For researchers and clinicians alike, the availability of PTHLH gene knockout cell lines presents an invaluable resource for expanding our understanding of skeletal health, thereby contributing to the development of novel treatments. Our company specializes in providing high-quality biological products designed for advanced research applications, ensuring that scientists have access to the tools necessary for groundbreaking discoveries in the field of molecular and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.